| |
Diagnosis
|
|---|
| |
CHC n 36
|
FL n 45
|
NASH n 42
|
|---|
| |
Gender
|
Mean
|
SD
|
Gender
|
Mean
|
SD
|
Gender
|
Mean
|
SD
|
|---|
|
Age
| |
44.5
|
10.0
| |
42.3
|
9.1
| |
40.4
|
10.5
|
|
TGF-β1 ng/mL*
| |
87.5
|
39.5
| |
129.1
|
45.4
| |
116.8
|
42.2
|
|
CRP
| | | | |
0.8
|
0.4
| |
0.9
|
0.4
|
|
ALT U/L#
| |
72.7
|
25.6
| |
49.2
|
17.8
| |
54.3
|
21.8
|
|
Ferritin ng/mL
|
17 F
|
203.6
|
86.5
|
21 F
|
232.3
|
117.4
|
19 F
|
279.8
|
150.3
|
|
Ferritin ng/mL
|
19 M
|
396.4
|
153.5
|
24 M
|
381.5
|
137.2
|
23 M
|
357.2
|
132.3
|
|
Waist Circumference (cm)
| | | |
21 F
|
98
|
6.1
|
19 F
|
100
|
4.7
|
|
Waist Circumference (cm)
| | | |
24 M
|
105
|
6.3
|
23 M
|
108
|
7.7
|
|
HOMA
| | | | |
3.2
|
1.4
| |
3.4
|
1.5
|
| | |
Median
|
Range
| |
Median
|
Range
| |
Median
|
Range
|
|
BMI‡
| |
26
|
22–30
| |
29
|
27–32
| |
29
|
27–32
|
|
Fibrosis score
| |
1
|
1–3
| | | | |
1
|
1–2
|
|
US steatosis Score
| |
2
|
1–3
| | | | |
1
|
1–3
|
- CHC, chronic hepatitis C; FL, fatty liver; NASH, non-alcoholic steatohepatitis; ALT, alanine aminotransferase; CRP, C reactive protein; TGF-β1, transforming growth factor beta1; BMI, body mass index; HOMA, homeostasis model assessment-insulin resistance index.
- * P < 0.001, FL versus CHC and 0.008, NASH versus CHC patients; # P < 0.001, CHC versus FL and NASH patients; ‡ P < 0.001, CHC versus FL and NASH patients.
